Compare Novo Nordisk A/S (NVO) vs Plug Power Inc (PLUG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Novo Nordisk A/S vs Plug Power Inc — how do they compare? Novo Nordisk A/S trades at $49.31 (market cap $220.53B), while Plug Power Inc trades at $2.27 (market cap $2.98B). The key difference: Novo Nordisk A/S is far larger — about 74× Plug Power Inc's market cap, and Novo Nordisk A/S pays a 3.63% dividend while Plug Power Inc pays none. Which is the better fit depends on your goals.
| NVO | PLUG | |
|---|---|---|
Market Cap | $220.53B | $2.98B |
Sector | Health | Industrials |
52-Week High | $71.70 | $4.14 |
52-Week Low | $35.29 | $1.40 |
Enterprise Value | $239.49B | $3.77B |
Dividend Yield | 3.63% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Plug Power (PLUG) trades at $2.27, up 5.58% on the day, but remains in a bearish technical trend with oversold RSI readings. The company shows persistent unprofitability with a -227.13% net margin and negative cash flows, though recent earnings have beaten estimates in two of the last three quarters. Positive developments include a 50-megawatt electrolyzer order in Australia and strategic asset sales aimed at boosting liquidity by over $275 million, providing some operational momentum amid financial challenges.
The outlook remains high-risk due to deep losses and cash burn, but analyst consensus is cautiously optimistic with a $2.92 price target (28% upside). Investment opportunity hinges on successful turnaround execution and hydrogen demand growth, while key risks include continued dilution, competitive pressure, and reliance on financing to fund operations. The stock's depressed valuation reflects significant skepticism, leaving room for volatility on news flow.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Novo Nordisk A/S
With almost 50% market share by volume of the global insulin market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments, and oral antidiabetic agents. Novo also has a biopharmaceutical segment (constituting roughly 15% of revenue) that specializes in protein therapies for hemophilia and other disorders.
Read more on NVO →About Plug Power Inc
Plug Power is building an end-to-end green hydrogen ecosystem—from production, storage and delivery to energy generation. The company plans to build and operate green hydrogen highways across North America and Europe. Plug will deliver its green hydrogen solutions directly to its customers and through joint venture partners into multiple end markets—including material handling, e-mobility, power generation, and industrial applications.
Read more on PLUG →
